AUTOIMMUNE LYMPHOPROLIFERATIVE
Clinical trials for AUTOIMMUNE LYMPHOPROLIFERATIVE explained in plain language.
Never miss a new study
Get alerted when new AUTOIMMUNE LYMPHOPROLIFERATIVE trials appear
Sign up with your email to follow new studies for AUTOIMMUNE LYMPHOPROLIFERATIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a stem cell transplant cure severe immune disorders?
⭐️ CURE ⭐️ Recruiting nowThis study tests if a stem cell transplant can cure people with severe immune system diseases. Participants receive healthy blood stem cells from a donor to rebuild their immune system. The study includes 66 people aged 4 to 69 who have not responded to standard treatments. The g…
Matched conditions: AUTOIMMUNE LYMPHOPROLIFERATIVE
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: ⭐️ CURE ⭐️
Last updated May 26, 2026 06:43 UTC
-
New hope for rare immune disorders: Pre-Transplant inflammation dampening
Disease control Recruiting nowThis study tests two treatments (emapalumab or fludarabine plus dexamethasone) to reduce inflammation before a stem cell transplant in people with primary immune regulatory disorders. The goal is to help the donated stem cells settle in and start making healthy immune cells. Abou…
Matched conditions: AUTOIMMUNE LYMPHOPROLIFERATIVE
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
Could a stem cell transplant fix broken immune systems?
Disease control Recruiting nowThis study is testing whether a stem cell transplant from a healthy donor can safely treat people with severe immune system problems. Participants (ages 4-75) receive chemotherapy and then donor stem cells, followed by a hospital stay and years of monitoring. The goal is to see i…
Matched conditions: AUTOIMMUNE LYMPHOPROLIFERATIVE
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 14, 2026 12:06 UTC